MARCON, ALESSIA
 Distribuzione geografica
Continente #
EU - Europa 2.647
NA - Nord America 2.559
AS - Asia 2.171
SA - Sud America 256
AF - Africa 109
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.757
Nazione #
US - Stati Uniti d'America 2.495
GB - Regno Unito 888
CN - Cina 827
SG - Singapore 615
IT - Italia 418
DE - Germania 295
SE - Svezia 294
BR - Brasile 190
HK - Hong Kong 187
RU - Federazione Russa 179
IN - India 128
TR - Turchia 103
NL - Olanda 96
IE - Irlanda 86
UA - Ucraina 84
CI - Costa d'Avorio 71
FR - Francia 63
KR - Corea 63
ID - Indonesia 59
FI - Finlandia 57
DK - Danimarca 48
VN - Vietnam 44
CA - Canada 38
PL - Polonia 37
EU - Europa 33
GR - Grecia 28
JP - Giappone 28
CO - Colombia 26
TH - Thailandia 25
MX - Messico 15
BE - Belgio 14
AR - Argentina 13
CH - Svizzera 13
PK - Pakistan 13
AU - Australia 12
IR - Iran 12
AT - Austria 10
BD - Bangladesh 10
ES - Italia 10
TW - Taiwan 7
ZA - Sudafrica 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
IQ - Iraq 6
KE - Kenya 6
UZ - Uzbekistan 6
EC - Ecuador 5
MA - Marocco 5
OM - Oman 5
PH - Filippine 5
PY - Paraguay 5
VE - Venezuela 5
CL - Cile 4
AL - Albania 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BO - Bolivia 2
CY - Cipro 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LB - Libano 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CM - Camerun 1
CR - Costa Rica 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
Totale 7.788
Città #
Southend 823
Singapore 363
Chandler 284
Ashburn 268
Beijing 206
Milan 198
Hong Kong 183
Dallas 145
Frankfurt am Main 134
Seattle 119
Princeton 107
Fairfield 96
Ann Arbor 90
Dublin 86
Wilmington 84
Abidjan 71
Council Bluffs 71
Jacksonville 65
Santa Clara 64
Houston 61
Dearborn 56
Los Angeles 54
Bengaluru 53
Woodbridge 52
Nanjing 42
Des Moines 41
Istanbul 40
Boardman 39
Shenyang 34
Warsaw 34
Munich 33
Redmond 33
Mountain View 32
Jinan 31
Buffalo 27
Jakarta 26
Cambridge 24
Phoenix 23
Redwood City 23
Shanghai 23
New York 22
Changsha 21
Tokyo 21
Andover 20
Bogotá 20
Hebei 20
São Paulo 20
Cangzhou 19
Columbus 18
Sakarya 18
Serra 16
Tianjin 16
Toronto 16
Moscow 15
Bitonto 14
Brussels 14
Fuzhou 14
Guangzhou 14
The Dalles 14
Falls Church 12
Ho Chi Minh City 12
Somerville 12
Sunnyvale 12
Athens 11
Fremont 11
Helsinki 11
Jiaxing 11
Nanchang 11
Rome 11
Grafing 10
Hangzhou 10
Hefei 10
Hyderabad 10
San Diego 10
Belo Horizonte 9
Hanoi 9
Regina 9
Auburn Hills 8
Bangkok 8
Berlin 8
Chiang Mai 8
Haikou 8
Kunming 8
Thessaloniki 8
Islamabad 7
London 7
Rio de Janeiro 7
Semarang 7
Seoul 7
Zhengzhou 7
Dhaka 6
Montreal 6
Nuremberg 6
San Francisco 6
Amsterdam 5
Baku 5
Bussero 5
Irvine 5
Kent 5
Medford 5
Totale 4.913
Nome #
A holistic approach to iron chelation therapy in transfusion-dependent thalassemia patients with serum ferritin below 500 μg/L 316
Adrenal insufficiency: An emerging challenge in thalassemia? 294
Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma 283
Low-dose Synachten test with measurement of salivary cortisol in adult patients with β-thalassemia major 274
Beta-thalassaemia intermedia : evaluation of endocrine and bone complications 213
Pregnant women affected by thalassemia major : a controlled study of traits and personality 191
Bone mineralization in patients with beta-thalassemia intermedia (TI) 187
Thalassemic osteopathy : a new marker of bone deposition 184
Complicanze endocrinologiche nella talassemia major 179
The spectrum of ocular alterations in patients with β-Thalassemia Syndromes suggests a pathology similar to pseudoxanthoma elasticum 177
Molecular characterization of haemoglobin variants in Lombardia 170
Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with beta-thalassemia intermedia 167
The effect of Deferasirox on myocardial iron overload and cardiac function : a prospective independent monocentric study using cardiovascular magnetic resonance T2 165
Coagulopathy in beta-thalassemia : current understanding and future perspectives 165
Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major 165
Iron metabolism in macrophages in Non trasfusion dependent Thalassemia 162
Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy 162
Innovative Treatments for Rare Anemias 156
Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in Northern Italy in the last 15 years 155
Transcranial color Doppler in stroke-free adult patients with sickle cell disease 153
Pulmonary dysfunction in thalassaemia major : is there any relationship with body iron stores? 150
Clinical Complications and Their Management 150
The genetic compound β thal / α α α genes causes severe anemia during pregnancy requiring blood transfusions 145
Pulmonary dysfunction in thalassemia major and correlations with body iron stores 145
Pulmonary hypertension (ph) in patients with beta thalassaemia intermedia 144
Acute splenic sequestration crisis (ASSC) in sickle cell syndromes 143
Spine bone texture assessed by trabecular bone score (TBS) to evaluate bone health in Thalassemia major 143
Polymorphisms in TMPRSS6 gene are risk factors for iron deficiency and iron deficiency anemia 142
Splenic and liver involvement in Sickle cell disease 136
Clinical complications in adult patients with sickle cell anemia and β-thalassemia-sickle cell disease 134
Pulmonary hypertension (PH) in patients with beta thalassaemia intermedia 133
Utility in clinical practice of a new severity score index (GAUSSI-I) in patients with Gaucher disease 133
Priapism, an emerging complication in β-thalassemia intermedia patients 131
Growth differentiation factor 15 expression and regulation during erythroid differentiation in non transfusion dependent thalassemia syndromes 128
Bone quality in beta-thalassemia intermedia : relationships with bone quantity and endocrine and hematologic variables 127
Management of age-associated medical complications in patients with β-thalassemia 127
Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT) 124
Clinical features in sickle cell disease 123
Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with beta-thalassemia intermedia 119
Loss of weight: observing the patient versus lab tests 118
Transient elastography to assess liver fibrosis in patients with sickle cell disease 118
Cardiac and liver involvement assessed by T2* magnetic resonance (MRI T2*) in patients with thalassemia major 116
In vitro ferroportin expression in non trasfusion depedent thalassemia during erythroid differentiation 112
Cardiac iron overload examinated by T2* magnetic resonance (MRI T2*) in a cohort of thalassemia major patients 111
Transcranial color doppler ultrasonography in adult patients with sickle cell disease 111
Analysis of TMPRSS6 polymorphisms in patients with iron deficiency anemia partially responsive to oral iron treatment 110
Splenomegaly: Dare to think rare 110
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 108
Transcranial color doppler sonography and magnetic resonance imaging in adult patients with Sickle cell disease 105
Pre- and post-trasfusional cardiac function evaluated by echocardiography in Thalassemia major patients 102
Caratterizzazione molecolare di varianti emoglobiniche in Lombardia 100
Therapy of Sickle Cell Disease 97
Transcranial color doppler in adult patients with sickle cell disease 92
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial 87
Pregnancy in patients with thalassemia major : a cohort study and conclusions for an adequate care management approach 78
Totale 8.170
Categoria #
all - tutte 23.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021490 0 0 0 0 0 50 28 66 89 47 168 42
2021/2022647 47 41 32 35 76 33 49 26 67 50 34 157
2022/2023958 100 106 86 93 157 161 12 76 94 20 33 20
2023/2024525 26 44 20 36 143 26 25 20 20 22 66 77
2024/20251.498 49 165 20 171 132 49 87 135 82 135 111 362
2025/20261.298 310 193 261 209 309 16 0 0 0 0 0 0
Totale 8.170